Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology - 1 Feb 2010

Stirnimann Guido, Petitprez Séverine, Abriel Hugues, Schwick Nicola G

Abstract excerpt

A patient with an SCN5A p.W822X nonsense mutation, localized in the transmembrane region DII-S4 of the Na(v)1.5 sodium channel and leading to a non-expression of the mutant allele, was prescribed the selective serotonin reuptake inhibitor (SSRI) fluvoxamine (Floxyfral), 100 mg per day. His normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brugada Syndrome
Share to Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electrocardiography

Share to Fluvoxamine

Share to Muscle Proteins

Share to NAV1.5 Voltage-Gated Sodium Channel

Share to Selective Serotonin Reuptake Inhibitors

Share to Sodium Channels

Source

Identifiers

PMID: 19875396
DOI: 10.1093/europace/eup332

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19875396-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine.PMID 19875396Read ↗

Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.Semantic proximity Read ↗

Patient with obstructive sleep apnea-hypopnea syndrome and SCN5A mutation (R1193Q polymorphism) associated with Brugada type 2 electrocardiographic pattern.Semantic proximity Read ↗

Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.Semantic proximity Read ↗

Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.Semantic proximity Read ↗

Flecainide test in Brugada syndrome: a reproducible but risky tool.Semantic proximity Read ↗

Antiarrhythmic Action of Flecainide in Polymorphic Ventricular Arrhythmias Caused by a Gain-of-Function Mutation in the Nav 1.5 Sodium Channel.Semantic proximity Read ↗

Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.Semantic proximity Read ↗

Block of the human ether-a-go-go-related gene (hERG) K+ channel by the antidepressant desipramine.Semantic proximity Read ↗

Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community.Semantic proximity Read ↗

Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.Semantic proximity Read ↗

Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.